| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00004481721 |
| 005 |
20191203081120.0 |
| 008 |
950601s1995 enka b 001 0 eng d |
| 020 |
|
|
|a 1872748775
|
| 035 |
|
|
|a (OCoLC)32626400
|
| 035 |
|
|
|9 AAG4995MS
|
| 035 |
|
|
|z (UtOrBLW)20823
|
| 035 |
|
|
|a 33578
|
| 040 |
|
|
|a NLM
|c NLM
|d UtOrBLW
|
| 049 |
|
|
|a TMVM
|c 1
|
| 060 |
0 |
0 |
|a 1995 E-085
|
| 060 |
1 |
0 |
|a QW 805
|b M157h 1995
|
| 069 |
0 |
|
|a 9507446
|
| 096 |
|
|
|a QW 805
|b M157h 1995
|
| 100 |
1 |
|
|a Mackett, M.
|
| 245 |
1 |
0 |
|a Human vaccines and vaccination /
|c M. Mackett, J.D. Williamson.
|
| 264 |
|
1 |
|a Oxford :
|b BIOS Scientific Publishers,
|c 1995.
|
| 264 |
|
2 |
|a Herndon, Va. :
|b Books International [distributor].
|
| 300 |
|
|
|a xv, 215 pages :
|b illustrations (some color) ;
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 490 |
1 |
|
|a Medical perspectives series
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Communicable diseases: The problem and some solutions -- An overview of communicable diseases -- A short history of vaccine development: Jenner's legacy -- Vaccination practice in developed countries -- Vaccination practice in developing countries -- The need for new and improved vaccines -- References -- Etiological agents of communicable diseases requiring new or improved human vaccines -- Viruses -- Bacteria -- Chlamydia -- Parasitic protozoa -- Parasitic helminths -- Mechanisms of pathogenesis -- Anatomical sites used by pathogens to gain entry into the human body -- Localized infections -- Systemic infections -- Organs or tissues targeted by pathogens following their systemic spread -- Oncogenic virus infections -- Opportunistic virus infections -- Transmission of infectious diseases -- Innate and required immune responses.
|
| 505 |
0 |
|
|a Innate responses to infection -- Acquired immune responses to infection -- Humoral immunity -- Cell-mediated immunity -- T lymphocytes -- Antigens -- Cytokines -- References -- Immune responses to infectious and parasitic diseases -- Innate immunity -- Acquired immunity -- Antigenic diversity.
|
| 505 |
0 |
|
|a Antigenic complexity -- Latent infections -- Modulation of immune responses -- Immune evasion -- Anamnestic immune responses -- Protective immune responses -- References -- Identification and analysis of vaccine antigens -- The role of molecular biology in vaccine development -- Identification and cloning of antigens -- Characterization of vaccine antigens: B-cell epitopes -- Characterization of vaccine antigens: T-cell epitopes -- References -- Developing new vaccines: Inactivated and subunit approaches -- Inactivated vaccines -- Expression systems and subunit vaccines -- Peptide vaccines -- Anti-idiotypes -- Genetic immunization -- Issues of presentation -- References -- New and improved live attenuated vaccines -- Improving attenuation: Pseudorabies- a veterinary vaccine pardigm -- Improving attenuation: V. cholerae -- Improving stability: Poliovirus -- Recombinant live vectors -- Vaccinia virus recombinants.
|
| 505 |
0 |
|
|a Cross-species vaccination: 'Live-dead' vaccines -- BCG -- Attenuated salmonella strains as live recombinant bacterial vaccines -- Poliovirus chimeras -- Other virus vectors -- Recombinant e. coli strains.
|
| 505 |
0 |
|
|a Improving immunogenicity: Examples from vaccinia virus -- References -- EBV vaccine development: A laboratory-based case study -- Natural history and clinical significance of EBV -- Rationale for EBV program -- Vaccine design for EBV -- Identification and characterization of EBV antigens -- Vaccines based on gp340 -- References -- HBV vaccines- from the laboratory to license: A case study -- Epidemiology and disease in HBV infection -- HBV structure -- HBV vaccines -- Problems -- Further development -- Practical considerations: From laboratory to arm -- References -- Discussion -- Why vaccinate?- prevention is better than cure -- Herd immunity and its control of infectious and parasitic diseases -- Elimination of an infectious disease: Smallpox eradication -- The argument for expanded programs of immunization -- The need for new or improved vaccines -- Sterile immunity: Is it possible? -- New and re-emerging infectious diseases -- References.
|
| 650 |
|
2 |
|a Vaccines.
|
| 650 |
|
2 |
|a Vaccination.
|
| 650 |
|
2 |
|a Immunotherapy, Active.
|
| 650 |
|
2 |
|a Communicable Diseases
|x immunology.
|
| 700 |
1 |
|
|a Williamson, J. D.
|
| 830 |
|
0 |
|a Medical perspectives series.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s a347190c-17be-3387-866b-340ecf30b4d4
|i e84b1469-577f-371d-9f65-3b0b1ce27a07
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e QW 805 M157h 1995
|h National Library of Medicine classification
|i unmediated -- volume
|m 323890118399D
|
| 998 |
f |
f |
|a QW 805 M157h 1995
|t 0
|l Remote Storage
|